Assessing the validity of self-reported medication adherence in hepatitis C treatment

Annals of Pharmacotherapy

Volumn 41, Issue 7-8, 2007, Pages 1116-1123

  Smith, Scott R ^a,b,g   Wahed, Abdus S ^c   Kelley, Stephanie S ^c   Conjeevaram, Hari S ^d   Robuck, Patricia R ^e   Fried, Michael W ^f  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Hepatitis C; Measurement; Medication adherence

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; ELECTRONIC SENSOR; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; VALIDITY;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 34547222990     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K024     Document Type: Article

References (11)

1. Raptopoulou M, Tsantoulas D, Vafiadi I, et al. The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C participants. J Viral Hepat 2005;12:91-5.
2. Conjeevaram HS, Fried MW, Jeffers LJ, et al. Peginterferon and ribavirin treatment in African American patients and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 2006;131:470-7.
3. Gilbert JR, Evans CE, Haynes RB, Tugwell P. Predicting compliance with a regimen of digoxin therapy in family practice. Can Med Assoc J 1980;123:119-22.
4. Du Pasquier-Fediaevsky L, Tubiana-Rufi N. Discordance between physician and adolescent assessments of adherence to treatment. Diabetes Care 1999;22:1445-9.
5. Brody DS. Physician recognition of behavioral, psychologic, and social aspects of medical care. Arch Intern Med 1980;140:1286-9.
6. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-66.
7. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening participant adherence and barriers to adherence. Patient Educ Couns 1999;37:113-24.
8. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-7.
9. Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care STDS 2006;20:628-36.
10. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-77.
11. Pekovic V, Mayanja H, Vjecha M, et al. Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. Uganda-Case Western Reserve University Research Collaboration. J Clin Epidemiol 1998;51:597-607.